About
RNAi
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapySan Diego & Southern California
Clinical Trials (47)
View allTotal Trials
47
As Lead Sponsor
46
As Collaborator
1
Total Enrollment
6,504
By Phase
PHASE3: 7PHASE1/PHASE2: 10PHASE1: 14PHASE2: 15
By Status
COMPLETED: 17TERMINATED: 10RECRUITING: 8ACTIVE_NOT_RECRUITING: 8WITHDRAWN: 3AVAILABLE: 1
Clinical Trials Pipeline46 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07037771Lead Sponsor
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
PHASE3Recruiting
60 participants
Started: Jun 17, 2025 · Completed: Aug 20, 2027
NCT06937203Lead Sponsor
Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes Mellitus
PHASE1/PHASE2Recruiting
126 participants
Started: May 7, 2025 · Completed: Jul 31, 2026
NCT06880770Lead Sponsor
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
PHASE3Recruiting
140 participants
Started: Apr 24, 2025 · Completed: Jun 30, 2029
NCT06822790Lead Sponsor
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
PHASE3Recruiting
869 participants
Started: Apr 9, 2025 · Completed: Jul 31, 2028
NCT06672445Lead Sponsor
Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
PHASE1Recruiting
36 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Pasadena, CA, United States
Map
Loading map...